ZEB1 and breast cancer: In particular, Chaffer et al. showed that, in sub-populations of breast cancer cells, the promoter of ZEB1, a master regulator of epithelial-to-mesenchymal transition, is maintained in an inactive, bivalent state and that loss of bivalency in these cells is induced in response to TGFβ [14].